Bath & Body Works (NYSE:BBWI) Hits New 1-Year Low – Time to Sell?

Shares of Bath & Body Works, Inc. (NYSE:BBWI) reached a new 52-week low during mid-day trading on Saturday . The stock traded as low as $24.93 and last traded at $25.11, with a volume of 10541740 shares changing hands. The stock had previously closed at $26.29.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Wall Street Zen lowered shares of Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. UBS Group dropped their target price on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Morgan Stanley dropped their target price on shares of Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a report on Friday, September 12th. JPMorgan Chase & Co. boosted their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an “overweight” rating in a report on Monday, July 28th. Finally, Barclays upped their price objective on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an “equal weight” rating in a report on Friday, August 29th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $39.69.

Bath & Body Works Stock Down 4.5%

The firm’s 50-day moving average price is $29.58 and its 200 day moving average price is $29.74. The company has a market capitalization of $5.18 billion, a P/E ratio of 7.45, a P/E/G ratio of 0.86 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the prior year, the firm posted $0.37 EPS. The firm’s quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works’s dividend payout ratio is presently 23.74%.

Institutional Investors Weigh In On Bath & Body Works

A number of institutional investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. grew its position in shares of Bath & Body Works by 7.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after acquiring an additional 781,681 shares during the period. JPMorgan Chase & Co. grew its position in shares of Bath & Body Works by 11.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after acquiring an additional 733,000 shares during the period. Victory Capital Management Inc. grew its position in shares of Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock valued at $206,119,000 after acquiring an additional 6,752,274 shares during the period. Alliancebernstein L.P. grew its position in shares of Bath & Body Works by 5.8% during the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after acquiring an additional 315,738 shares during the period. Finally, Cooper Creek Partners Management LLC grew its position in shares of Bath & Body Works by 42.7% during the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after acquiring an additional 1,619,276 shares during the period. 95.14% of the stock is owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.